Jozef Dragašek
Biographic Data
| ID | 7640468 |
|---|---|
| NAME | Jozef Dragašek |
| GIVEN NAMES | Jozef |
| FAMILY NAME | Dragašek |
| SIGNATURE | DRAGAŠEK J |
| AFFILIATIONS | University of Pavol Jozef Šafárik |
| ORCID | 0000-0003-2938-6675 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Study protocol for identification of patients with risk of cognitive impairment in advanced pharmaceutical care in a community pharmacy
Introduction: Cognitive impairment (CI) is a growing public health problem. Our study is based on the fact that cognitive assessment in community pharmacy focused on early identification of undiagnosed CI has received limited attention. As pharmacists are the most accessible health professionals due to the availability of community pharmacies to the public, they have the potential to bring improvement in this area. Early identification of at-risk…
Factors associated with psychiatric and physical comorbidities in bipolar disorder
This cross-national study has reported novel estimates and clinical correlates related to both the comorbidity-free phenotype and the factors associated with psychiatric and physical comorbidities in adults with BD in Slovakia. The findings provide new insights into understanding of the clinical presentation of BD that can inform clinical practice and further research to continue to investigate potential mechanisms of BD adverse outcomes and dise…
No prominent works on this page.
Factors associated with psychiatric and physical comorbidities in bipolar disorder
This cross-national study has reported novel estimates and clinical correlates related to both the comorbidity-free phenotype and the factors associated with psychiatric and physical comorbidities in adults with BD in Slovakia. The findings provide new insights into understanding of the clinical presentation of BD that can inform clinical practice and further research to continue to investigate potential mechanisms of BD adverse outcomes and dise…
Study protocol for identification of patients with risk of cognitive impairment in advanced pharmaceutical care in a community pharmacy
Introduction: Cognitive impairment (CI) is a growing public health problem. Our study is based on the fact that cognitive assessment in community pharmacy focused on early identification of undiagnosed CI has received limited attention. As pharmacists are the most accessible health professionals due to the availability of community pharmacies to the public, they have the potential to bring improvement in this area. Early identification of at-risk…
Medicine (2 works) · Psychiatry (2 works) · Alternative medicine (1 work) · Bipolar disorder (1 work) · Bipolar Disorder and Treatment (1 work) · Cancer-related cognitive impairment studies (1 work) · Cognition (1 work) · Cognitive impairment (1 work) · Comorbidity (1 work) · Cross-sectional study (1 work)